Mucopolysaccharidosis II [mukopolysacharidóza II]
- Terms
-
deficit iduronát-2-sulfatázy
Hunterova choroba
Hunterova nemoc
Hunterův syndrom
lyzozomální nedostatek enzymu iduronát-2-sulfatázy
MPS II
mukopolysacharidóza II. typu
mukopolysacharidóza typu 2
mukopolysacharidóza typu II
mukopolysacharidóza, typ II
-
Gargoylism, Hunter Syndrome
Hunter Syndrome
Hunter Syndrome Gargoylism
Hunter's Syndrome
I2S Deficiency
Iduronate 2-Sulfatase Deficiency
Iduronate Sulfatase Deficiency
Mucopolysaccharidosis 2
Mucopolysaccharidosis Type 2
Mucopolysaccharidosis Type II
Sulfoiduronate Sulfatase Deficiency
Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.
- DUI
- D016532 MeSH Browser
- CUI
- M0025232
- Previous indexing
- Mucopolysaccharidosis I (1966-1991)
- History note
- 1992; for MUCOPOLYSACCHARIDOSIS 2 and HUNTER'S SYNDROME use LIPOCHONDRODYSTROPHY 1976-1991
- Public note
- 1992; for MUCOPOLYSACCHARIDOSIS 2 and HUNTER'S SYNDROME see LIPOCHONDRODYSTROPHY 1976-1991
Allowable subheadings
- BL
- blood
- CF
- cerebrospinal fluid
- CI
- chemically induced
- CL
- classification
- CO
- complications 1
- DI
- diagnosis 14
- DG
- diagnostic imaging
- DH
- diet therapy
- DT
- drug therapy 3
- EC
- economics 1
- EM
- embryology
- EN
- enzymology 3
- EP
- epidemiology 1
- EH
- ethnology
- ET
- etiology 3
- GE
- genetics 11
- HI
- history
- IM
- immunology
- ME
- metabolism
- MI
- microbiology
- MO
- mortality
- NU
- nursing
- PS
- parasitology
- PA
- pathology 5
- PP
- physiopathology 5
- PC
- prevention & control 1
- PX
- psychology
- RT
- radiotherapy
- RH
- rehabilitation
- SU
- surgery
- TH
- therapy 6
- UR
- urine
- VE
- veterinary
- VI
- virology